ICS 2016 Scientific Podium Express Session S13 - Rapid Communications in Urology

Rapid Communications in Urology

Speakers
	Scientific Podium Express Session S13
	Wednesday 14th September 2016
	16:00 - 17:30
	Hall D5 Capacity: 200
	Lunch provided
R Roger Roman Dmochowski ICS Chair N Noritoshi Sekido ICS Chair M Myung-Soo Choo ICS Chair
Professional interest
Urology

Session Schedule

16:00

#215 A randomized control trial comparing silodosin and urapidil in female patients with lower urinary tract symptom –interim report-

Presenter: Koichi Sugimoto

Sugimoto K¹, Shimizu N², Hashimoto M¹, Matsumura N³, Hongoh S¹, Minami T¹, Nishioka T³, Akiyama T⁴, Uemura H¹
1. Dept of Urology, Kindai University Hospital Faculty of Medicine, Osaka-Sayama, Osaka, Japan, 2. Dept of Urology, University of Pittsburgh, Kindai University Hospital Faculty of Medicine, 3. Dept of Urology, Kindai University Sakai Hospital Faculty of Medicine, Sakai, Osaka, Japan, 4. Dept of Urology, Sakai-Onshinkai Hospital, Sakai, Osaka, Japan
Female, Outcomes Research Methods, Clinical Trial

16:03

#216 Safety and efficacy of mirabegron add-on treatment to solifenacin in OAB subjects in comparison to solifencin monotherapy. A meta-analysis of randomized controlled trials .

Presenter: Omar Naser

Naser O¹, Elgebaly A², Menshawy A², Kamal Y³, Negida A³, Gana B¹
1. West Wales General Hospital, 2. Al-Azhar University, 3. Zagazig University
Overactive Bladder, Pharmacology, Clinical Trial

16:06

#217 A meta-analysis of long- versus short-acting phosphodiesterase 5 inhibitors: comparing combination use with α-blockers and α-blocker monotherapy for lower urinary tract symptoms

Presenter: Jae Hyun Bae

Choi H¹, Bae J H¹, Yeo J K², Seo J T³, Lee J G¹
1. Dept. of Urology, Korea Universtiy, 2. Dept. of Urology, Inje University Seoul Paik Hospital, Inje University, 3. Department of Urology, Cheil General Hospital, Dankook University College of Medicine, Seoul, Republic of Korea
Male, Pharmacology, Benign Prostatic Hyperplasia (BPH)

16:09

#218 CAN FEELING OF INCOMPLETE BLADDER EMPTYING REFLECT SIGNIFICANT POSTVOID RESIDUAL URINE? IS IT RELIABLE AS A SYMPTOM SOLELY?

Presenter: Zafer Aybek

Ozlulerden Y¹, Toktas C², Zümrütbas A E², Gulten M C², Baser A², Yapici O³, Aybek Z²
1. Ataturk State Hospital, 2. Pamukkale University Medical Faculty, 3. Acipayam State Hospital
Voiding Dysfunction , Questionnaire, Male, Female

16:12

#219 Videourodynamic study of dysfunctional voiding in female voiding dysfunction – the role of urethral sphincter and pelvic floor muscles

Presenter: Chung-Hsin Peng

Peng C¹, Ong H², Lee Y², Kuo H²
1. Department of Urology, Cardinal Tien Hospital, An Kang, New Taipei City, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Urodynamics Techniques, Voiding Dysfunction , Female

16:15

#220 Differences between the Valsalva manoeuvre and straining to generate a rise in intra-abdominal pressure (IAP).

Presenter: Dina El-Hamamsy

El-Hamamsy D¹, Watson A¹, Corden J², Reid F¹, Smith A¹
1. Warrell Unit, St Mary's Hospital, Central Manchester Foundation Trust., 2. Central Manchester Foundation Trust.
Terminology, Biomechanics, Pelvic Organ Prolapse, Incontinence

16:18

#221 Urethral sphincter volume and urodynamic diagnoses.

Presenter: Roopali Karmarkar

Karmarkar R¹, Fernando R¹, Regan L², Khullar V¹
1. Imperial College London, 2. Imperial Colleg London
Anatomy, Basic Science, Female, Imaging, Incontinence

16:21

#222 Artificial urinary sphincter implantation in women with stress urinary incontinence: preliminary comparison of the robot-assisted and open approaches

Presenter: Benoit Peyronnet

Peyronnet B¹, Vincendeau S¹, Tondut L¹, Pradere B¹, Gires B¹, Freton L¹, Alimi Q¹, Senal N¹, Bonan I¹, Bensalah K¹, Kerdraon J¹, Manunta A²
1. Rennes University Hospital, 2. Rennes University Hopsital
Female, Stress Urinary Incontinence, Incontinence, Surgery

16:24

#223 Introduction to the new Aroyo® Artificial Urinary Sphincter and the relationship of adjustable and quantifiable device pressure to pad weight reduction

Presenter: Matthias Oelke

Zachoval R¹, Haillot O², Krhut J³, Thiruchelvam N⁴, Chlosta P⁵, Lynch W⁶, Moon D⁷, Chin P⁸, LeNormand L⁹, Hansen F¹⁰, Cornu J¹¹, Oelke M¹²
1. Thomayer Hospital and 1st and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic, 2. CHU Bretonneau and University Francois Rabelais, Tours, France, 3. Dept. of Urology, Faculty Hospital, Ostrava, Czech Republic, 4. Department of Urology, Cambridge University Hospitals NHS Trust , Cambridge, United Kingdom, 5. Department of Urology, Collegium Medicum of the Jagiellonian University, Cracow, Poland, 6. St George Hospital, Kogarah, NSW, Australia, 7. Royal Melbourne Hospital, Melbourne, Australia, 8. The Wollongong Hospital, Wollongong, NSW, Australia, 9. CHU de Nantes, Nantes, France, 10. Herlev & Gentofte Hospital, Herlev, Denmark, 11. Department of Urology, Rouen University Hospital, Rouen, France, 12. Hannover Medical School, Germany
Stress Urinary Incontinence, New Devices, Pad Test, Clinical Trial, Male

16:27

#224 Core lower urinary tract symptom score in patients with pelvic organ prolapse

Presenter: Tsuyoshi Yoshizawa

Yoshizawa T¹, Yamaguchi K¹, Murata Y¹, Sato K¹, Matsui T¹, Mochida J¹, Takahashi S¹
1. Department of Urology, Nihon University School of Medicine
Female, Pelvic Organ Prolapse, Voiding Dysfunction , Questionnaire

16:30

#225 Clinical and Urodynamic Features Associated with Detrusor Overactivity in Women with Lower Urinary Tract Symptoms

Presenter: Alex Digesu

Cavalcanti G¹, Bray R², Ford A², Bhawana P², Cartwright R², Fernando R², Khullar V², Digesu A²
1. Hospital Universitário Oswaldo Cruz/University of Pernambuco (HUOC/UPE), and Instituto de Medicina Integral Prof. Fernando Figueira (IMIP) – Recife – Brazil. CAPES Foundation, Ministry of Education of Brazil, Brasília – Brazil, 2. Department of Urogynaecology, Imperial College Healthcare Trust, London, UK
Detrusor Overactivity, Female, Overactive Bladder, Retrospective Study, Voiding Dysfunction

16:33

#226 Sleep apnea and circadian extracellular fluid change as an independent factor for nocturnal polyuria.

Presenter: Aya Niimi

Niimi A¹, Suzuki M², Yamaguchi Y³, Fujimura T¹, Igawa Y⁴, Homma Y¹
1. The University of Tokyo, Department of Urology, 2. Tokyo Teishin Hospital, Department of Urology, 3. The University of Tokyo, Department of Geriatric Medicine, 4. The University of Tokyo, Department of Continence Medicine
Gerontology, Nocturia, Voiding Diary

16:36

#227 Prognostic factors for changes of erectile function before and after treatment in sleep apnea patients: is there a role for nocturia? A controlled study

Presenter: Apostolos Apostolidis

Daskalopoulou-Vlahogianni E¹, Apergis N¹, Sokolakis I², Kouvatseas G³, Mouzakitis G³, Vlachogiannis E⁴, Apostolidis A²
1. Sleep Laboratory, Agios Pavlos Hospital, Thessaloniki, Greece, 2. 2nd Department of Urology, Aristotle University of Thessaloniki, Greece, 3. Health Data Specialists, Athens, Greece, 4. Department of Internal Medicine, Agios Pavlos Hospital, Thessaloniki, Greece
Nocturia, Questionnaire, Sexual Dysfunction , Quality of Life (QoL)

16:39

#228 GENDER DIFFERENCES IN DIURESIS, WITH A FOCUS ON COPEPTIN

Presenter: Elke Bruneel

Bruneel E¹, Goessaert A¹, Denys M¹, Norgaard J P², Everaert K¹
1. UZ Gent, 2. Ferring Pharmaceuticals, Copenhagen
Voiding Diary, Physiology, Retrospective Study

16:42

#229 DIURNAL VARIATION OF COPEPTIN, A SURROGATE OF VASOPRESSIN

Presenter: Elke Bruneel

Bruneel E¹, Juul K², Norgaard J P², Everaert K¹
1. UZ Gent, 2. Ferring Pharmaceuticals, Copenhagen
Biochemistry , Nocturia, Physiology

16:45

#230 THE CIRCADIAN RHYTHM OF POST-VOID RESIDUALS IN A NORMAL POPULATION OF INSTITUTIONALIZED OLDER PEOPLE WITH NOCTURIA

Presenter: Candy Kumps

Kumps C¹, Decalf V¹, Denys M¹, Huion A², Petrovic M¹, Everaert K¹
1. Ghent University Hospital, 2. University College Ghent
Voiding Dysfunction , Voiding Diary, Nocturia, Nursing, Pathophysiology

16:48

#231 Exploring nocturia in an older population

Presenter: Marie-Astrid Denys

Denys M¹, Decalf V¹, Bruneel E¹, Kumps C¹, Velghe A¹, Petrovic M¹, Everaert K¹
1. Ghent University Hospital
Nocturia, Gerontology, Pathophysiology

16:51

#232 Unravelling nocturnal polyuria in older patients

Presenter: Marie-Astrid Denys

Denys M¹, Decalf V¹, Bruneel E¹, Kumps C¹, Velghe A¹, Petrovic M¹, Everaert K¹
1. Ghent University Hospital
Nocturia, Gerontology, Pathophysiology

16:54

#233 Development of TANGO, a novel screening tool to identify non-LUTS causes of Nocturia.

Presenter: Wendy Bower

Bower W¹, Ervin C², Whishaw M³, Khan F¹
1. Department of Rehabilitation Medicine, Melbourne Health, 2. Sub-Acute community Services, Melbourne Health, 3. Departments of Aged Care and Urology, Melbourne Health
Nocturia, New Instrumentation, Gerontology, Outcomes Research Methods, Questionnaire

16:57

#234 An Evaluation of SER120 Nasal Spray in Patients with Nocturia - Results of the Pooled Analyses of 2 Phase III Randomized, Double-Blind, Placebo Controlled Studies

Presenter: Alan Wein

Wein A¹, Dmochowski R², Cheng L³, Cheng M³, Abrams S⁴, Herschkowitz S³, Fein S³
1. University of Pennsylvania, 2. Vanderbilt University, 3. Serenity Pharmaceuticals, 4. Allergan plc
Clinical Trial, Nocturia, Quality of Life (QoL), Voiding Dysfunction

17:00

#235 Bidirectional relationship between nocturia and insomnia in a longitudinal study among Japanese men and women

Presenter: Yoshitaka Aoki

Aoki Y¹, Okada M¹, Yokoi S¹, Matsuta Y¹, Ito H¹, Matsumoto C², Kusaka Y¹, Yokoyama O¹
1. The University of Fukui Faculty of Medical Sciences, 2. The University of Fukui Faculty of Education and Regional Studies
Nocturia, Female, Male

17:03

#236 Seasonal Alterations in Nocturia: a Five-year Longitudinal Retrospective Study

Presenter: Shingo Kimura

Kimura S¹, Sato T², Orikasa K², Nakagawa H³
1. Iwate Prefectural Iwai hospital, 2. Kesennuma City Hospital, 3. Izumi Central Hospital
Nocturia, Quality of Life (QoL), Benign Prostatic Hyperplasia (BPH), Overactive Bladder, Detrusor Overactivity

17:06

#237 The risks of Intersitital cystitis among patients with Systemic lupus erythematosus: A Population-based Cohort Study

Presenter: JenYu Wen

Wen J¹, Ho C², Wu M¹
1. Department of Obstetrics and Gynecology, Chi-Mei Medical Center, Tainan, Taiwan, 2. Department of Medicine Research Chi Mei Medical Center,Tainan,Taiwan
Female, Retrospective Study, Painful Bladder Syndrome/Interstitial Cystitis (IC)

17:09

#238 2016 Cochrane Review: Intravesical Treatments For Bladder Pain Syndrome/ Interstitial Cystitis

Presenter: Abigail Ford

Ford A¹, Ballard P², Ramage C³, Ogah J⁴
1. Imperial College London, 2. Leeds General Infirmary, 3. Bradford Royal Infirmary, 4. University Hospital of Morecambe Bay
Painful Bladder Syndrome/Interstitial Cystitis (IC), Pain, Pelvic/Perineal, Quality of Life (QoL)

17:12

#239 Patient characteristics for different therapeutic strategies in the management ketamine cystitis

Presenter: Hui-Ling Yeh

Yeh H¹, Jhang J², Lee Y², Birder L³, Chancellor M⁴, Tian J², Kuo H²
1. Department of Nursing, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan, 3. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, USA, 4. William Beaumont School of Medicine, Oakland University, Royal Oak, Michigan, USA
Surgery, Pain, Pelvic/Perineal, Infection, other

17:15

#240 Depression need to be considered when managing the lower urinary tract symptoms among ketamine abusers

Presenter: I Chun Chen

Chen I C¹, Lee M H¹, Chen W C¹, Wu H C¹
1. Feng Yuan Hospital
Painful Bladder Syndrome/Interstitial Cystitis (IC), Voiding Dysfunction , Urgency/Frequency, Prevention

International Continence Society

Rapid Communications in Urology

Session Schedule

Comments

Chat